Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops and researches reagents for genome engineering and analysis, the technology used for gene therapy and natural health food products. It offers various medical devices including analytical reagents, single-cell analysis system and genome editing research reagents, among others. Takara services include instrument services, OEM and custom enzyme manufacturing, stem cell services, technical support, shipping and delivery, partnering and licensing and online tools. The company acts as a contract service provider involved in providing services in developing degenerative medicines and gene analysis services. Takara is headquartered in Kusatsu, Shiga, Japan.
Headquarters
Japan
Address
7-4-38, Noji-Higashi, Kusatsu-Shi, Shiga, 525-0058
Website
www.takara-bio.co.jp
Telephone
81 77 5656920
No of Employees
1,793
Industry
Medical Equipment
Ticker Symbol & Exchange
4974 (TYO)
Revenue (2023)
$577.3M
15.4%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
-19.3%
(2023 vs 2022)
Market Cap*
$965.4M
Net Profit Margin (2023)
XYZ
-30.1%
(2023 vs 2022)
* As of and is in US$
Takara Bio Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Next-Generation Sequencing: | Research and Development | Yamsgenin |
| RNA-Seq | Contract Research Services | |
| DNA-Seq | DNA Sequence Analysis | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | New Products/Services | In November, the company developed a novel adeno-associated virus (AAV) vector, SonuAAV. |
| 2022 | New Products/Services | In September, the company launched a new CDMO service for customers in the pharmaceutical and academic industries. |
| 2022 | New Products/Services | In July, the company launched a new CDMO service using a brain-tropic AAV (Adeno-associated Virus) vector CereAAV for customers in the gene and cell therapy industry. |
Competitor Comparison
| Key Parameters | Takara Bio Inc | Biofermin Pharmaceutical Co Ltd | Kidswell Bio Corp | CellSeed Inc | AnGes Inc |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Kusatsu-Shi | Kobe-Shi | Chuo-Ku | Koto-Ku | Ibaraki-Shi |
| State/Province | Shiga | Hyogo | Tokyo | Tokyo | Osaka |
| No. of Employees | 1,793 | 238 | 41 | 30 | 138 |
| Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Koichi Nakao | President; Director; Chief Executive Officer | Executive Board | - | - |
| Tsuyoshi Miyamura | Director; Senior Executive Officer | Executive Board | - | - |
| Junichi Mineno | Director; Executive Officer; Vice President | Executive Board | - | - |
| Katsuhiko Kusakabe | Director; Senior Executive Officer | Executive Board | - | - |
| Yoh Hamaoka | Senior Executive Officer; Director | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward